Download PDF
CC BY 4.0 · Arq Neuropsiquiatr 2023; 81(09): 795-802
DOI: 10.1055/s-0043-1772603
Original Article

Clinical characteristics of headaches in an urban Mennonite group in South Brazil

Características clínicas das cefaleias em um grupo menonita urbano do sul do Brasil
David Lemke Dück 
1   Universidade Federal do Paraná, Setor de Ciências da Saúde, Curitiba PR, Brazil.
,
Marco Antonio Takashi Utiumi 
2   Clínica de Neurologia São José, Centro de Cefaleia, São José dos Pinhais PR, Brazil.
,
Angelica Beate Winter Boldt 
3   Universidade Federal do Paraná, Departamento de Genética, Curitiba PR, Brazil.
,
Elcio Juliato Piovesan 
2   Clínica de Neurologia São José, Centro de Cefaleia, São José dos Pinhais PR, Brazil.
4   Universidade Federal do Paraná, Departamento de Clínica Médica, Curitiba PR, Brazil.
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

Background Genetic variants play a pathophysiological role in headaches, especially in migraine. The Mennonite group (MG) has been geographically and genetically isolated throughout its history, harboring a distinctive distribution of diseases.

Objective To determine the characteristics of headaches in a group with direct Mennonite ancestry contrasting with other urban community members (control group [CG]).

Methods Subjects with headaches were asked to complete a questionnaire covering: the type of headache, presence of aura, frequency and duration of attacks, pain location and severity, analgesic consumption, premonitory and postdromic manifestations, Depressive Thoughts Scale, Epworth Sleepiness Scale (ESS), General Anxiety Disorder-7, Patient Health Questionnaire-9 (PHQ-9), Migraine Disability Assessment, and Composite Autonomic System Score.

Results We included 103 participants (CG: 45, Mennonite group [MG]: 58). Migraine was the most common headache (CG: 91.1%; MG: 81.0%; p = 0.172), followed by tension-type headache (CG: 8.9%; MG: 15.5%; p = 0.381). Aura was identified by 44.4% and 39.7% in the CG and MG, respectively (p = 0.689). The groups differed only concerning the frequency of retro-orbital pain (CG: 55.6%; MG: 32.8%; p = 0.027), PHQ-9 (CG: median 7, range 0 to 22; MG: median 5, range 0 to 19; p = 0.031) and ESS (CG: median 0, range 0 to 270; MG: median 0, range 0 to 108; p = 0.048) scores.

Conclusion There were no major differences in the prevalence and clinical characterization of headaches between the MG and the CG. However, the latter showed more diffuse pain, sleepiness, and depressive symptoms. Specific genetic or epigenetic variants in Mennonite descendants might account for these differences.

Resumo

Antecedentes Variantes genéticas desempenham um papel fisiopatológico nas cefaleias, especialmente na migrânea. O grupo menonita (GM) tem estado geográfica e geneticamente isolado ao longo de sua história, abrigando uma distribuição distinta de doenças.

Objetivo Determinar as características das cefaleias em um grupo com ascendência menonita direta, comparando-as com as de outros membros da comunidade urbana (grupo controle [GC]).

Métodos Participantes com cefaleia foram convidados a preencher um questionário abrangendo: tipo de cefaleia; presença de aura; frequência e duração dos ataques; localização e gravidade da dor; consumo de analgésicos; manifestações premonitórias e posdrômicas; Escala de Pensamentos Depressivos; Escala de Sonolência de Epworth (ESS); Transtorno de Ansiedade Geral-7 (GAD-7); Questionário de Saúde do Paciente-9 (PHQ-9); Avaliação de Incapacidade da Migrânea (MIDAS) e Escore do Sistema Autônomo Composto (COMPASS-31).

Resultados Incluímos 103 participantes (GC: 45, GM: 58). A migrânea foi a cefaleia mais frequente (GC: 91,1%; GM: 81,0%; p = 0,172), seguida pela cefaleia tensional (GC: 8,9%; GM: 15,5%; p = 0,381). Aura foi identificada por 44,4% e 39,7% nos GC e GM, respectivamente (p = 0,689). Os grupos diferiram apenas com relação à frequência de dor retro-orbitária (GC: 55,6%; GM: 32,8%; p = 0,027), PHQ-9 (GC: mediana 7, amplitude 0 a 22; GM: mediana 5, amplitude 0 a 19; p = 0,031) e ESS (GC: mediana 0, amplitude 0 a 270; GM: mediana 0, amplitude 0 a 108; p = 0,048).

Conclusão Não houve diferenças significativas na prevalência e caracterização clínica das cefaleias nos GM e GC. Entretanto, o último grupo mostrou mais dor difusa, sonolência e sintomas depressivos. Variantes genéticas ou epigenéticas específicas em descendentes de menonitas podem justificar tais diferenças.

Keywords

Reproductive Isolation - Migraine Disorders - Urban Population - Headache

Palavras-chave

Isolamento Reprodutivo - Transtornos de Enxaqueca - População Urbana - Cefaleia

Authors' Contributions

DLD: Conceptualization, data curation, formal analysis, investigation, methodology, writing – original draft, writing – review and editing; MATU: Conceptualization, formal analysis, writing – original draft, writing – review and editing; ABWB: Conceptualization, funding acquisition, investigation, methodology, supervision, writing – original draft, writing – review and editing; EJP: Conceptualization, investigation, methodology, project administration, supervision, writing – original draft, writing – review and editing.


Support

ABWB received a research productivity scholarship from the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq, in the Portuguese acronym) (protocol number: 314288/2018-0).




Publication History

Received: 13 March 2023

Accepted: 26 May 2023

Article published online:
04 October 2023

© 2023. Academia Brasileira de Neurologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 

  • References

  • 1 Lopes FL, Hou L, Boldt ABW. et al. Finding rare, disease-associated variants in isolated groups: potential advantages of Mennonite populations. Hum Biol 2016; 88 (02) 109-120
    CrossrefPubMedGoogle Scholar
  • 2 Boldt MC, Oliveira LC, Kretzschmar GC. et al. Depression and health self-perception: associations within the isolated Mennonite population in South Brazil. J Immigr Minor Health 2020; 22 (06) 1265-1272
    CrossrefPubMedGoogle Scholar
  • 3 Orton NC, Innes AM, Chudley AE, Bech-Hansen NT. Unique disease heritage of the Dutch-German Mennonite population. Am J Med Genet A 2008; 146A (08) 1072-1087
    CrossrefPubMedGoogle Scholar
  • 4 Pardo-Seco J, Llull C, Berardi G. et al. Genomic continuity of Argentinean Mennonites. Sci Rep 2016; 6: 36392
    CrossrefPubMedGoogle Scholar
  • 5 Saunders-Pullman R, Fuchs T, San Luciano M. et al. Heterogeneity in primary dystonia: lessons from THAP1, GNAL, and TOR1A in Amish-Mennonites. Mov Disord 2014; 29 (06) 812-818
    CrossrefPubMedGoogle Scholar
  • 6 Melton PE, Zlojutro M, Kimminau K, Crawford MH. Biological aging and Cox hazard analysis of mortality trends in a Mennonite community from south-central Kansas. Am J Hum Biol 2006; 18 (03) 387-401
    CrossrefPubMedGoogle Scholar
  • 7 Demarchi DA, Mosher MJ, Crawford MH. Apolipoproteins (apoproteins) and LPL variation in Mennonite populations of Kansas and Nebraska. Am J Hum Biol 2005; 17 (05) 593-600
    CrossrefPubMedGoogle Scholar
  • 8 Toscanini U, Brisighelli F, Llull C. et al. Charting the Y-chromosome ancestry of present-day Argentinean Mennonites. J Hum Genet 2016; 61 (06) 507-513
    CrossrefPubMedGoogle Scholar
  • 9 GBD 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2018; 17 (11) 954-976
    CrossrefPubMedGoogle Scholar
  • 10 GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017; 390 (10100): 1211-1259
    CrossrefPubMedGoogle Scholar
  • 11 Queiroz LP, Peres MFP, Piovesan EJ. et al. A nationwide population-based study of tension-type headache in Brazil. Headache 2009; 49 (01) 71-78
    CrossrefPubMedGoogle Scholar
  • 12 Queiroz LP, Peres MFP, Piovesan EJ. et al. A nationwide population-based study of migraine in Brazil. Cephalalgia 2009; 29 (06) 642-649
    CrossrefPubMedGoogle Scholar
  • 13 Vetvik KG, MacGregor EA. Sex differences in the epidemiology, clinical features, and pathophysiology of migraine. Lancet Neurol 2017; 16 (01) 76-87
    CrossrefPubMedGoogle Scholar
  • 14 Schoonman GG, Evers DJ, Terwindt GM, van Dijk JG, Ferrari MD. The prevalence of premonitory symptoms in migraine: a questionnaire study in 461 patients. Cephalalgia 2006; 26 (10) 1209-1213
    CrossrefPubMedGoogle Scholar
  • 15 Lucas C. Migraine with aura. Rev Neurol (Paris) 2021; 177 (07) 779-784
    CrossrefPubMedGoogle Scholar
  • 16 Giffin NJ, Lipton RB, Silberstein SD, Olesen J, Goadsby PJ. The migraine postdrome: An electronic diary study. Neurology 2016; 87 (03) 309-313
    CrossrefPubMedGoogle Scholar
  • 17 Edvinsson L, Haanes KA, Warfvinge K, Krause DN. CGRP as the target of new migraine therapies - successful translation from bench to clinic. Nat Rev Neurol 2018; 14 (06) 338-350
    CrossrefPubMedGoogle Scholar
  • 18 Edvinsson L, Tajti J, Szalárdy L, Vécsei L. PACAP and its role in primary headaches. J Headache Pain 2018; 19 (01) 21
    CrossrefPubMedGoogle Scholar
  • 19 Lassen LH, Haderslev PA, Jacobsen VB, Iversen HK, Sperling B, Olesen J. CGRP may play a causative role in migraine. Cephalalgia 2002; 22 (01) 54-61
    CrossrefPubMedGoogle Scholar
  • 20 Hautakangas H, Winsvold BS, Ruotsalainen SE. et al; International Headache Genetics Consortium, HUNT All-in Headache, Danish Blood Donor Study Genomic Cohort. Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk alleles. Nat Genet 2022; 54 (02) 152-160
    CrossrefPubMedGoogle Scholar
  • 21 Gormley P, Kurki MI, Hiekkala ME. et al; 23andMe Research Team, International Headache Genetics Consortium (IHGC). Common variant burden contributes to the familial aggregation of migraine in 1,589 families. Neuron 2018; 98 (04) 743-753.e4
    CrossrefPubMedGoogle Scholar
  • 22 Fila M, Sobczuk A, Pawlowska E, Blasiak J. Epigenetic connection of the calcitonin gene-related peptide and its potential in migraine. Int J Mol Sci 2022; 23 (11) 6151
    CrossrefPubMedGoogle Scholar
  • 23 Carneiro AM, Baptista MN. Development and psychometric properties of Depressive Thoughts Scale - EPD. Rev Bras Ter Cogn 2012; 8 (02) 74-84
    Google Scholar
  • 24 Bertolazi AN, Fagondes SC, Hoff LS, Pedro VD, Menna Barreto SS, Johns MW. Portuguese-language version of the Epworth sleepiness scale: validation for use in Brazil. J Bras Pneumol 2009; 35 (09) 877-883
    CrossrefPubMedGoogle Scholar
  • 25 Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006; 166 (10) 1092-1097
    CrossrefPubMedGoogle Scholar
  • 26 Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16 (09) 606-613
    CrossrefPubMedGoogle Scholar
  • 27 Fragoso YD. MIDAS (Migraine Disability Assessment): a valuable tool for work-site identification of migraine in workers in Brazil. Sao Paulo Med J 2002; 120 (04) 118-121
    CrossrefPubMedGoogle Scholar
  • 28 Sletten DM, Suarez GA, Low PA, Mandrekar J, Singer W. COMPASS 31: a refined and abbreviated Composite Autonomic Symptom Score. Mayo Clin Proc 2012; 87 (12) 1196-1201
    CrossrefPubMedGoogle Scholar
  • 29 Headache Classification Committee of the International Headache Society (IHS). Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018; 38 (01) 1-211
    CrossrefPubMedGoogle Scholar
  • 30 Maniyar FH, Sprenger T, Monteith T, Schankin C, Goadsby PJ. Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks. Brain 2014; 137 (Pt 1): 232-241
    CrossrefPubMedGoogle Scholar
  • 31 Russell MB, Rasmussen BK, Fenger K, Olesen J. Migraine without aura and migraine with aura are distinct clinical entities: a study of four hundred and eighty-four male and female migraineurs from the general population. Cephalalgia 1996; 16 (04) 239-245
    CrossrefPubMedGoogle Scholar
  • 32 Queiroz LP, Peres MFP, Kowacs F. et al. Chronic daily headache in Brazil: a nationwide population-based study. Cephalalgia 2008; 28 (12) 1264-1269
    CrossrefPubMedGoogle Scholar
  • 33 Utiumi MAT, Küster JGB, Godk KS. et al. Prevalence of trigeminocervical convergence mechanisms in episodic and chronic migraine. Arq Neuropsiquiatr 2022; 80 (05) 482-489
    Article in Thieme ConnectPubMedGoogle Scholar
  • 34 Maestri M, Romigi A, Schirru A. et al. Excessive daytime sleepiness and fatigue in neurological disorders. Sleep Breath 2020; 24 (02) 413-424
    CrossrefPubMedGoogle Scholar
  • 35 Buse DC, Reed ML, Fanning KM, Bostic RC, Lipton RB. Demographics, headache features, and comorbidity profiles in relation to headache frequency in people with migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study. Headache 2020; 60 (10) 2340-2356
    CrossrefPubMedGoogle Scholar